Respiratory Treatment and Prevention (Advances in Experimental Medicine and Biology)

(Jacob Rumans) #1

Table 6 Comorbidities in patients with and without malaria


Malaria (n¼15) (%) No malaria (n¼38) (%) p-value
Acute bronchitis 0 1 (2.6) 0.526
Acute respiratory distress syndrome 1 (6.7) 0 0.108
Acute tonsillitis 0 1 (2.6) 0.526
Acute urinary tract infection 0 1 (2.6) 0.526
Appendectomy 0 4 (10.5) 0.191
Benign prostatic hyperplasia 0 1 (2.6) 0.526
Cataract 0 1 (2.6) 0.526
Chronic bronchitis 0 1 (2.6) 0.526
Chronic osteomyelitis 0 1 (2.6) 0.526
Chronic polyarthritis 0 1 (2.6) 0.526
Chronic renal failure 0 1 (2.6) 0.526
Condition after brain tumor 0 1 (2.6) 0.526
Condition after stroke 0 1 (2.6) 0.526
Dehydration 1 (6.7) 0 0.108
Diabetes 0 2 (5.3) 0.365
Disseminated intravascular coagulation 1 (6.7) 0 0.108
Drug abuse 0 1 (2.6) 0.526
Early abortion 1 (6.7) 0 0.108
Erysipelas 0 1 (2.6) 0.526
Fecal impaction 0 1 (2.6) 0.526
Fatty liver 0 1 (2.6) 0.526
Hemolytic anemia 0 1 (2.6) 0.526
Hemorrhoid 1 (6.7) 0 0.1081
Herniated disc 0 1 (2.6) 0.526
Hypertension 1 (6.7) 3 (7.9) 0.879
Hyperlipidemia 0 2 (5.3) 0.365
Hypertensive heart disease 0 1 (2.6) 0.526
Hysterectomy 0 1 (2.6) 0.526
Infection of unknown origin 0 2 (5.3) 0.365
Inflammatory response syndrome 1 (6.7) 0 0.108
Influenza 1 (6.7) 8 (21.1) 0.209
Iron deficiency anemia 1 (6.7) 0 0.108
Liver cirrhosis 0 1 (2.6) 0.526
Mycoplasma pneumonia 0 1 (2.6) 0.526
Nicotine 0 3 (7.9) 0.263
Obesity 0 1 (2.6) 0.526
Osteoarthritis 0 1 (2.6) 0.526
Otitis 0 1 (2.6) 0.526
Paracetamol intoxication 1 (6.7) 0 0.108
Pregnancy 1 (6.7) 0 0.108
Reflux esophagitis 1 (6.7) 0 0.108
Sepsis 0 1 (2.6) 0.526
State after hepatitis A 1 (6.7) 0 0.108
State after hepatitis B 1 (6.7) 1 (2.6) 0.487
State after hepatitis C 0 2 (5.3) 0.365
State after amebiasis 0 1 (2.6) 0.526
State after disc surgery 0 1 (2.6) 0.526
State after groin surgery 1 (6.7) 1 (2.6) 0.487
State after herpes zoster 1 (6.7) 0 0.108
(continued)

42 J. Yayan and K. Rasche

Free download pdf